Figure S3. MiR-196b has no response to E2 treatment in ER+ BC cells. (A) ER+ BC cells MCF7 and ER- BC cells MDA-MB-231 were cultured with estrogen-free medium for 72 h before E2 treatment, then treated with 10 nM E2 or equal amount of solvent Eth as solvent control for 0, 3, 6, 12 or 24 h. The expression levels of miR-196b were analyzed by qRT-PCR and U6 levels were used as internal control, and normalized to the values of the Eth control. Data were presented as the means ± SD from three independent experiments with triple replicates per experiment. * and ** indicate significant difference compared to the 0 h group at P < 0.05 and P < 0.01, respectively. (JPEG 37 kb
Figure S1. Target miRNA expression in breast cancer, by lymphovascular invasion (LV invasion) status...
Figure S2. Breast cancer-secreted EVs did not regulate osteoclast differentiation. Mouse bone marrow...
miRNA expression in MDA-MB-231 cells. RNA was isolated from MDA-MB-231 cells and subjected to RT-qPC...
Figure S2. Estrogen induces tumor growth of ER+ but ER- BC cells via the regulation of miR-196a. The...
Figure S1. MiR-196a is up-regulated in ER+ BC tissues. (A, B) Two different GEO2R datasets GSE58215 ...
Figure S7. SPRED1 reverses miR-196a-induced malignant phenotype of BC cells. MiR-196a- or miR-NC-ove...
Figure S10. The densities of CD31 levels were analyzed in tumor tissues with changes of miR-196a. MC...
Figure S9. The correlation between SPRED1 and ESR1 expression levels. (A) Pearsonâs correlation an...
(a-f) Expression levels of miR-17-5p and miR-106b-5p were measured by RT-qPCR in HK-2, RCC-Shaw and ...
Hs-578 T cells were exposed to 0, 10 or 20 μM GLA for 48 h, and conditioned media was collected. (A)...
Figure S1. miR-140-3p-1 modestly inhibits proliferation of breast preneoplastic cells. (A) Immunoflu...
Figure S1. Transfection with the multi-miRNA (cluster) lentiviral vector significantly enhanced T-DM...
Figure S2. The inhibition of miR-155 in adipocytes attenuates the invasiveness of co-cultured tumour...
Table S1. Sequence of DNMT3B siRNA. Table S2. Primers of miR-29c and DNMT3B. Table S3. Primers of TI...
Figure S2. MiR-223-3p suppressed tumor growth in vivo. (a) Tumor growth curves measured after intrat...
Figure S1. Target miRNA expression in breast cancer, by lymphovascular invasion (LV invasion) status...
Figure S2. Breast cancer-secreted EVs did not regulate osteoclast differentiation. Mouse bone marrow...
miRNA expression in MDA-MB-231 cells. RNA was isolated from MDA-MB-231 cells and subjected to RT-qPC...
Figure S2. Estrogen induces tumor growth of ER+ but ER- BC cells via the regulation of miR-196a. The...
Figure S1. MiR-196a is up-regulated in ER+ BC tissues. (A, B) Two different GEO2R datasets GSE58215 ...
Figure S7. SPRED1 reverses miR-196a-induced malignant phenotype of BC cells. MiR-196a- or miR-NC-ove...
Figure S10. The densities of CD31 levels were analyzed in tumor tissues with changes of miR-196a. MC...
Figure S9. The correlation between SPRED1 and ESR1 expression levels. (A) Pearsonâs correlation an...
(a-f) Expression levels of miR-17-5p and miR-106b-5p were measured by RT-qPCR in HK-2, RCC-Shaw and ...
Hs-578 T cells were exposed to 0, 10 or 20 μM GLA for 48 h, and conditioned media was collected. (A)...
Figure S1. miR-140-3p-1 modestly inhibits proliferation of breast preneoplastic cells. (A) Immunoflu...
Figure S1. Transfection with the multi-miRNA (cluster) lentiviral vector significantly enhanced T-DM...
Figure S2. The inhibition of miR-155 in adipocytes attenuates the invasiveness of co-cultured tumour...
Table S1. Sequence of DNMT3B siRNA. Table S2. Primers of miR-29c and DNMT3B. Table S3. Primers of TI...
Figure S2. MiR-223-3p suppressed tumor growth in vivo. (a) Tumor growth curves measured after intrat...
Figure S1. Target miRNA expression in breast cancer, by lymphovascular invasion (LV invasion) status...
Figure S2. Breast cancer-secreted EVs did not regulate osteoclast differentiation. Mouse bone marrow...
miRNA expression in MDA-MB-231 cells. RNA was isolated from MDA-MB-231 cells and subjected to RT-qPC...